Skba Capital Management LLC Viatris Inc Transaction History

Skba Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$9.81 - $15.4 $5.52 Million - $8.66 Million	-562,300 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$12.09 - $14.68 $641,241 - $778,612	53,039 Added 10.41%	562,300 $7.61 Million
Q3 2021 Nov 10, 2021	BUY	$13.25 - $15.13 $236,777 - $270,373	17,870 Added 3.64%	509,261 $6.9 Million
Q2 2021 Aug 12, 2021	SELL	$12.97 - $16.15 $2.09 Million - $2.6 Million	-161,047 Reduced 24.68%	491,391 $7.02 Million
Q1 2021 May 13, 2021	BUY	$13.59 - $18.54 $4.57 Million - $6.24 Million	336,376 Added 106.43%	652,438 $9.12 Million
Q4 2020 Feb 10, 2021	BUY	$14.3 - $18.74 $4.52 Million - $5.92 Million	316,062 New	316,062 $5.92 Million

1,100

969M

2.63M

2.15M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $14B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Skba Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Skba Capital Management LLC with notifications on news.